Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hope you get something out of them ... thanks anyhow for taking this up
Well, we'll see. I do think that if news come this will be a wild ride. This one has a history of 'exploding' upon news.
I explained you my strategy. So far it's been working.
I have no doubt that news still needs to come and expect the plot to unfold.That's where I again will sell some and hold on to a larger part. I do agree that this is taking too long and thus understand the frustration/ bashing of some on this board.
I don't care for the conversions at current as it is logical a company needs to raise funds.
For my understanding : where do you get the output of the outstanding shares ? Love it as it gives you a direct view on what they 'printed' on extra.
It's going back to its lows ... so I'm buying between 0.0033 and 0.0049.
Without news it will go back up after the conversions, with news it will go faster.
Been playing this one for over two years. Part is my fixed position, the other to lower my avg buy price.
Added ...
60 million
More then an hour left to open and we already are close to trading 10 million shares ... this will be a fun day !
HIGHER :)
Moonmarket video .... speaking about STGZ ... we're being loaded
Taking too long, plus all the fluff tweets are just undermining their credibility ...
Have not sold, so do hope they get their act straightened out
LOL... so we already had it
Strange $BRBL (sistercompany) does not rs ...
Don't know most read through the fillings, but the A/S is rs'd as well to 50 million. Something is up ...
On March 3, 2023, following the approval of the Board of Directors of BrewBilt Manufacturing, Inc., a Florida corporation (the “Company”), the Company filed Articles of Amendment to the Company’s Articles of Incorporation (the “Articles of Amendment”) to effect a reverse stock split of the Company’s common stock, par value $0.0001 per share (the “Common Stock”), as of March 10, 2023, at a ratio of 1-for-300 (the “Reverse Stock Split”) pursuant to Section 607.10025 of the Florida Business Corporation Act (the “FBCA”). Because the Reverse Stock Split also reduces the authorized shares of Common Stock in the same proportion as the Reverse Stock Split, from 15,000,000,000 shares to 50,000,000 shares, shareholder approval is not required to effect the Reverse Stock Split pursuant to Section 607.10025(2) of the FBCA.
That's a year ago ...
Seems news must be close
Well, lots of Twitter messages from IDGC ... seems they're pumping their own company. Let's hope it works :)
I got my ducks lined up and ready to fly high ...
Pfff ... taking toooo long ... but I'll hold
Correctomundo ... and someone will have to cover ...
786 must be the target price for TRKA :)
They're first celebrating ...
Nope - out of the picture
No, it's trades ...
BioRestorative Therapies Receives Notice of Allowance by the United States Patent and Trademark Office for a Patent Application Related to its ThermoStem® Program
Source: GlobeNewswire Inc.?
BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage company focused on stem cell-based therapies, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company’s metabolic ThermoStem® program. The notice of allowance was issued on February 24, 2023.
This will be the third patent granted under this particular family of intellectual property, claims granted under the new patent cover implantable three-dimensional scaffolds and brown adipocytes that have been derived from human brown adipose-derived stem cells. Therapeutic benefits of using brown adipose have been demonstrated in various models and may provide a valuable therapeutic tool for treating a range of metabolic disorders. In addition, BioRestorative is evaluating the use of this technology to target indications outside of metabolic disorders.
“This is the second notice of allowance we have received regarding our ThermoStem® program within 2023. This notice of allowance is very meaningful as it provides the Company with further protection and strengthens our technology as we develop and expand into the clinic. Additionally, it enhances our ability to engage with the strategic community on collaborative and partnering opportunities” said Lance Alstodt, the Company’s CEO.
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:
• Disc/Spine Program (brtxDISC™): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person’s own) cultured mesenchymal stem cells collected from the patient’s bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patient’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patient’s damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have commenced a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.
• Metabolic Program (ThermoStem®): We are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (“BAT”). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events or results to differ materially from those projected in the forward-looking statements as a result of various factors and other risks, including, without limitation, those set forth in the Company's latest Form 10-K filed with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and the Company undertakes no obligation to update such statements.
CONTACT:
Email: ir@biorestorative.com
?
?
Look at that volume ... shorts shooting themselves in the foot
Yep and he's blowing his own grown stuff there
You turned negative on this one again ?
I know our patience is tested ...
Come to Daddy ... waiting to catch some extra
Correct
My bag is full :)
Added below 0.01
LOL - that's a coin with the picture of Klaus :)
I'm still in and even added yesterday - convinced the end game still has to start
Lots of weak hands gone. Would not be surprised this was orchestraded to buy up a part of the float. Remember that some institutional investors are in this one. Can't imagine they would agree on the offer ...
Cool, I'll buy. 0.0014/share if the deal goes through ...
What's so factual on this post ? Apart from it could go up, down and be careful, I don't see it ...
Good to have you on our side :)
Exaclty ! I've been buying for over 6 months now ... have not sold one share.
That's your opinion, not mine